Cure Gaba-A Poland

Cure Gaba-A Poland Naszą wizją jest przyszłość, w której osoby żyjące z wariantami GABA-A doświadczają lepszej jakości życia i mają dostęp do spersonalizowanych terapii.

04/21/2025

Charlie’s journey is one of resilience, love, and relentless pursuit of answers. Diagnosed with an ultra-rare GABRA2 genetic mutation, Charlie’s seizures beg...

CURE GABA-A | Ambassador NewsOne of our Spain Ambassadors, Roberto Gonzalez, a dedicated parent and team member of CURE ...
10/23/2024

CURE GABA-A | Ambassador News

One of our Spain Ambassadors, Roberto Gonzalez, a dedicated parent and team member of CURE GABA-A, traveled to attend the first day of the World Orphan Drug Congress in Barcelona. He’s actively networking in Europe and seeking opportunities for CURE GABA-A.

One key issue experts raised during the conferences was the excessive regulation in Europe, making it difficult to establish uniform protocols across all 27 EU countries.

He also wanted to share an exciting update!

Next week, we’ll begin collecting biosamples from three children through our recommended physician in Santander. He plans to freeze the samples and grow fibroblasts for two weeks before sending them to the COMBINEDBrain Biorepository under CURE GABA-A. This is an amazizing step towards growing our bio bank.

COMBINEDBrain - Outcome Measures and Biomarkers for Neurodevelopmental

CURE GABA-A | Medication Surveyhttps://filadelfia-science.dk/surveys/?s=TEX9JXNK3CPWTNA4As we approach the 2024 CURE GAB...
10/15/2024

CURE GABA-A | Medication Survey

https://filadelfia-science.dk/surveys/?s=TEX9JXNK3CPWTNA4

As we approach the 2024 CURE GABA-A Conference, we are excited to announce that Dr. Ortiz’s survey results, conducted by the Denmark team, will be presented by Dr. Rikke Møller.

Please click the link or scan the QR code to participate—it’s crucial that we share our medication data to advance toward more effective treatments.

This survey will contribute to a publication that will help ensure we receive the medications we need, prescribed by our physicians.

“We are working hard on the treatment survey - we will stop the inclusion of patients on the 24th of Oct, and then we need to perform the final data analysis.

In summary, we will have a lot to present at the end of this year :o)” - Dr. Rikke Møller

CURE GABA-A | Patient and Caregiver Storieshttps://curegabaa.org/submit-your-story/We will have all of our researchers g...
10/10/2024

CURE GABA-A | Patient and Caregiver Stories

https://curegabaa.org/submit-your-story/

We will have all of our researchers gathered in one room on December 6th for scientific day at our upcoming conference, and we’re planning to share patient stories with them.

This is your chance to have your story heard and seen by clinicians!

We’ll include a link to our stories tab on our website in the conference agenda, so if you haven’t done so already, please submit your story here:

CURE GABA-A | Gene therapy proposal!! We have some incredible news to share! Since our inception in 2023, CURE GABA-A ha...
10/07/2024

CURE GABA-A | Gene therapy proposal!!

We have some incredible news to share! Since our inception in 2023, CURE GABA-A has been dedicated to developing gene therapies for GABA-A receptor variants (GABAAR). We’ve curated an impressive database of researchers who share our vision: bringing therapeutics from bench to bedside (from the lab to our kids).

We’re thrilled to announce that Dr. Henry Lee, MPhil, PhD, Preclinical Scientific Program Manager Research Associate in Neurology at Harvard Medical School, has submitted a proposal through CURE GABA-A to explore gene replacement therapy (GRT) as a groundbreaking treatment for GABAAR-related disorders.

If awarded by Uplifting Athletes, this grant will be matched by CURE GABA-A, marking the fourth grant we’ve provided to researchers in the GABAAR space within just one year. We are advancing research by funding it!

The study aims to develop and test a novel AAV vector to deliver a functioning copy of the GABRA1 gene in mice. Positive outcomes could lead to new treatment approaches for other GABAAR variants, offering hope like never before.

Join us for an in-person conference in Los Angeles, California, at the OMNI hotel on December 5th & 6th, 2024. Registration is now open, and space is limited!

💰 Fundraising Efforts 💰
Fundraising is crucial right now—every dollar counts! Please create a classy fundraising page and share it with your friends and family. Our initial goal is to raise $2 million by the end of the year. If each family raises $5,000 to $10,000, we will reach our goal! That could be $1,000 from 10 friends or $100 from 100 people.

We’re also seeking volunteers to help us with our rapid growth. Our small team needs support to manage the influx of opportunities. Whether you can contribute an hour a week or up to 40 hours, we enthusiastically welcome your help. We need all hands on deck during this pivotal moment in our nonprofit and patient advocacy efforts. Your involvement is key!

For details, please email:
📧 monica@curegabaa.org
📧 agustina@curegabaa.org

Thank you for your continued support! Together, we can make a difference! 💖

CURE GABA-A website
https://www.CureGABAa.org

Conference Information
https://curegabaa.org/registration/

Fundraising
https://www.classy.org/campaign/cure-gaba-a/c559662

YouTube
https://www.youtube.com/channel/UCT8Du_C_8MKQvKLIyJO6DMQ



CURE GABA-A | Exciting News!!A new bio tech focused on gene therapy will collaborate with CURE GABA-A! Disclaimer: The E...
10/06/2024

CURE GABA-A | Exciting News!!

A new bio tech focused on gene therapy will collaborate with CURE GABA-A!

Disclaimer: The Elnekaveh Family has personally funded into the start-up Galibra Neuroscience, founded in 2023 by individuals with affiliations to Boston Children’s Hospital and Harvard Medical School.

While members of the family are involved in other non-profit and professional ventures, including CURE GABA-A, we maintain a clear separation of roles to prevent any potential conflicts of interest.

Galibra Neuroscience is an independent entity with its own leadership and operational framework. The co-founders, Henry Lee, MPhil, PhD, Senior Scientist and Program Manager at Boston Children’s Hospital, and Alexander Rotenberg, MD, PhD, Joseph J. Volpe Chair and Professor of Neurology at Boston Children’s Hospital, leverage their extensive experience and research to guide the company’s mission of improving patient outcomes.

Monica Joanna Elnekaveh serves as Founder and President of CURE GABA-A, while Amber Freed, Chief Development Officer, brings her expertise as the Founder & CEO of SLC6A1 Connect.

Galibra Neuroscience was founded in 2023 by a clinician and a scientist at Boston Children’s Hospital affiliated with Harvard Medical School. Our founders have over 25 years of experience in clinical care and translational research. We are directing our knowledge to improve patient lives.

CURE GABA-A | It was such a pleasure to sit down on the “Once Upon A Gene” podcast with Effie ParksTo share your story o...
09/27/2024

CURE GABA-A | It was such a pleasure to sit down on the “Once Upon A Gene” podcast with Effie Parks

To share your story on our website please visit: https://curegabaa.org/submit-your-story/

09/23/2024

CURE GABA-A | Important Announcement

We’re excited to announce the launch of our new page! 🎉

Over the next few months, we’ll be transitioning to this new page and appreciate your patience as we continue posting in both places until the official switch on December 5th, 2024, during the 2024 CURE GABA-A Conference.

Please feel free to start following us here: https://www.facebook.com/profile.php?id=61559328186052&mibextid=LQQJ4d

Thank you for your continued support!

Cure GABA-A is a non profit organization with the sole focus to develop potential therapies and treatments for GABA-A Variants by partnering with world renowned researchers in GABAAR and the organization of patients for clinical trials.

09/23/2024

CURE GABA-A | Gain of Function - GABRA1 Research & Support | Cure GABA-A

New Study Alert!

This study used molecular docking to examine how five approved AEDs:

Gaboxadol
Allopregnanolone
Cenobamate
Topiramate
Clobazam

and five emerging drugs:

Zolpidem
Eszopiclone
Suvorexant
Lemborexant
Bretazenil

Interact with the GABAAR’s α1 subunit.

Results show that emerging drugs like Zolpidem, Suvorexant, and Lemborexant have strong binding potential, suggesting they could improve seizure control.

Disclaimer:

The study shows promise for developing better epilepsy treatments but is limited by its focus on the alpha-1 subunit and static models, and further testing is needed to ensure the safety and effectiveness of these drugs before use.

CURE GABA-A | In-Person Conference | Los AngelesWe are so excited to announce a few of the speakers in this year’s in-pe...
09/21/2024

CURE GABA-A | In-Person Conference | Los Angeles

We are so excited to announce a few of the speakers in this year’s in-person CURE GABA-A conference!

Secure your tickets! Prices are $100/person per day

Tickets will increase to $150/person per day by October 15th

Dec 05th, 2024 - Family Meeting
Dec 05th, 2024 - Cocktail Party
Dec 06th, 2024 - Scientific Meeting

About the Event: https://curegabaa.org/conference-landing-page/

Secure tickets here: https://www.classy.org/event/2024-cure-gaba-a-conference/e605864/register/new/select-tickets

Discounted Hotel Room Block: https://curegabaa.org/registration/?et_fb=1&PageSpeed=off

Thank you to our sponsors CIRM and COMBINEDBrain

CURE GABA-A | We had an incredible meeting with Dr. Kathrin Meyers, a member of our scientific board, at our Malibu, Cal...
08/24/2024

CURE GABA-A | We had an incredible meeting with Dr. Kathrin Meyers, a member of our scientific board, at our Malibu, California headquarters to discuss AAV9, a virus used in gene therapy to deliver healthy genes into cells.

We’re excited to announce that we’re gearing up for our next big project: Gene Therapy! We’ll be sharing more details soon.

In the meantime, please continue to support our fundraising efforts—every dollar brings us closer to helping our children.

👉Donate directly: https://curegabaa.org/donate/

👉Create a fundraiser: https://www.classy.org/campaign/cure-gaba-a/c559662 #:~:text=Our%20mission%20is%20to%20advance,to%20contribute%20to%20the%20cause.

Address

580-21700 West Oxnard Street
Los Angeles, CA
91437

Alerts

Be the first to know and let us send you an email when Cure Gaba-A Poland posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cure Gaba-A Poland:

Share